Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lipocine (LPCN) Cash from Operations (2016 - 2025)

Lipocine's Cash from Operations history spans 13 years, with the latest figure at 2985723.0 for Q3 2025.

  • For Q3 2025, Cash from Operations fell 5.39% year-over-year to 2985723.0; the TTM value through Sep 2025 reached 5139287.0, down 3.92%, while the annual FY2024 figure was 1221233.0, 89.71% up from the prior year.
  • Cash from Operations reached 2985723.0 in Q3 2025 per LPCN's latest filing, down from 1886234.0 in the prior quarter.
  • In the past five years, Cash from Operations ranged from a high of 8994540.0 in Q4 2021 to a low of 6980787.0 in Q3 2021.
  • Average Cash from Operations over 5 years is 1910976.84, with a median of 2606032.0 recorded in 2023.
  • Peak YoY movement for Cash from Operations: skyrocketed 344.15% in 2021, then plummeted 181.8% in 2025.
  • A 5-year view of Cash from Operations shows it stood at 8994540.0 in 2021, then plummeted by 120.44% to 1838914.0 in 2022, then fell by 9.97% to 2022305.0 in 2023, then surged by 184.16% to 1701927.0 in 2024, then tumbled by 275.43% to 2985723.0 in 2025.
  • Per Business Quant, the three most recent readings for LPCN's Cash from Operations are 2985723.0 (Q3 2025), 1886234.0 (Q2 2025), and 1969257.0 (Q1 2025).